Aprea Company

Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.

Last Funding Type: Venture - Series Unknown
Funding Status: IPO
Headquarters: Stockholm, Stockholms Lan, Sweden
Founded Date: 2003
Investor Type: For Profit
Total Funding: $5.2M
Technology: Data-driven Technologies
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Investors Number: 2
Industry: PharmTech